Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)
:1167
Want to see HK:1167 full AI Analyst Report?
Total Valuation
Jacobio Pharmaceuticals Group Co., Ltd. has a market cap or net worth of HK$5.51B. The enterprise value is HK$4.55B.
Market CapHK$5.51B
Enterprise ValueHK$4.55B
Share Statistics
Jacobio Pharmaceuticals Group Co., Ltd. has 791,755,070 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding791,755,070
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jacobio Pharmaceuticals Group Co., Ltd.’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -15.15%.
Return on Equity (ROE)-0.18
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-15.15%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee202.88K
Profits Per Employee-553.32K
Employee Count257
Asset Turnover0.04
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Jacobio Pharmaceuticals Group Co., Ltd. is ―. Jacobio Pharmaceuticals Group Co., Ltd.’s PEG ratio is 3.12.
PE Ratio―
PS Ratio84.99
PB Ratio5.75
Price to Fair Value5.75
Price to FCF-23.66
Price to Operating Cash Flow-85.20
PEG Ratio3.12
Income Statement
In the last 12 months, Jacobio Pharmaceuticals Group Co., Ltd. had revenue of 52.14M and earned -142.20M in profits. Earnings per share was -0.18.
Revenue52.14M
Gross Profit29.35M
Operating Income-165.68M
Pretax Income-142.20M
Net Income-142.20M
EBITDA-143.46M
Earnings Per Share (EPS)-0.18
Cash Flow
In the last 12 months, operating cash flow was -55.44M and capital expenditures -913.77K, giving a free cash flow of -56.36M billion.
Operating Cash Flow-55.44M
Free Cash Flow-56.36M
Free Cash Flow per Share-0.07
Dividends & Yields
Jacobio Pharmaceuticals Group Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.04
52-Week Price Change80.88%
50-Day Moving Average6.55
200-Day Moving Average7.42
Relative Strength Index (RSI)66.45
Average Volume (3m)7.94M
Important Dates
Jacobio Pharmaceuticals Group Co., Ltd. upcoming earnings date is Aug 28, 2026, Before Open (Confirmed).
Last Earnings DateMar 9, 2026
Next Earnings DateAug 28, 2026
Ex-Dividend Date―
Financial Position
Jacobio Pharmaceuticals Group Co., Ltd. as a current ratio of 5.10, with Debt / Equity ratio of 21.43%
Current Ratio5.10
Quick Ratio5.10
Debt to Market Cap0.02
Net Debt to EBITDA1.66
Interest Coverage Ratio-13.15
Taxes
In the past 12 months, Jacobio Pharmaceuticals Group Co., Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Jacobio Pharmaceuticals Group Co., Ltd. EV to EBITDA ratio is -29.22, with an EV/FCF ratio of -22.39.
EV to Sales80.41
EV to EBITDA-29.22
EV to Free Cash Flow-22.39
EV to Operating Cash Flow-22.52
Balance Sheet
Jacobio Pharmaceuticals Group Co., Ltd. has HK$1.13B in cash and marketable securities with HK$165.24M in debt, giving a net cash position of HK$968.92M billion.
Cash & Marketable SecuritiesHK$1.13B
Total DebtHK$165.24M
Net CashHK$968.92M
Net Cash Per ShareHK$1.22
Tangible Book Value Per ShareHK$0.99
Margins
Gross margin is 78.03%, with operating margin of -317.76%, and net profit margin of -272.73%.
Gross Margin78.03%
Operating Margin-317.76%
Pretax Margin-272.73%
Net Profit Margin-272.73%
EBITDA Margin-275.15%
EBIT Margin-317.76%
Analyst Forecast
The average price target for Jacobio Pharmaceuticals Group Co., Ltd. is HK$11.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$11.00
Price Target Upside36.41% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-65.87%
EPS Growth Forecast6.71%